Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostatic Size Reduction Following the Administration of Leuprorelin Acetate in Localized Prostate Cancer Prior to Radiation Therapy. Pilot Study.

NCT06184464 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.

NCT NCT06184464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06184464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostatic Size Reduction Following the Administration of Leuprorelin Acetate in Localized Prostate Cancer Prior to Radiation Therapy. Pilot Study.
Lead sponsor
Consorci Sanitari de Terrassa
Phase
Observational
Overall status
Recruiting
Start date
February 2, 2024
Completion date
December 15, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer adenocarcinoma